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4 Abstract
5 The objective of this study was to identify changes in serum proteome in dogs that may occur 
6 after an experimental infection at subclinical and clinical stages of canine leishmaniosis (CanL).
7 For this purpose, canine pre- and post-infection with Leishmania infantum serum proteomes in 
8 the same dogs were analysed by a high-throughput label-based quantitative LC-MS/MS 
9 proteomic approach. A total of 169 proteins were identified, and 74 of them including 
10 complement C8 alpha chain, adiponectin, transferrin sphingomyelin phosphodiesterase acid like 
11 3A, and immunoglobulins showed different modulation between the different stages of CanL. 
12 These proteins could be considered as potential biomarkers in serum of early diagnostic or 
13 disease progression in CanL. Additionally, biological pathways modulated during CanL such as 
14 blood coagulation or gonadotropin-releasing hormone receptor were revealed, which could help 
15 to understand the pathological mechanisms of the disease. 
16
17 Keywords: biomarkers, dog diseases, Leishmania, proteomics, SWATH-MS.
18
19 1. Introduction
20 Visceral leishmaniosis is a global zoonosis caused by Leishmania spp parasites that is considered 
21 a major threat to human and animal health (Kuleš et al., 2016). Dogs are the main reservoirs of 
22 the disease (Miró et al., 2017), and canine leishmaniosis (CanL) is endemic in more than 70 
23 countries (Laia Solano-Gallego et al., 2011). CanL can produce a wide range of clinical 
24 presentations since it can potentially affect any organ or tissue, ranging from subclinical to fatal 
25 illness. Thus, the development of CanL is complex and often unpredictable, being their 
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1 The use of proteomics could bring more light and comprehension in the disease mechanisms, 
2 since it allows us to compare a high number of proteins simultaneously. This information can be 
3 used in order to identify the pathways and biological processes affected along the course of the 
4 disease. Proteomics has been widely used in the last few years in several canine diseases such as 
5 babesiosis (Kuleš et al., 2014), glomerular disease (Nabity et al., 2011), and leishmaniosis 
6 (Escribano et al., 2016; Martínez-Subiela et al., 2017), among others. The proteomics approach 
7 has also been employed for the identification of disease specific serum biomarkers and candidate 
8 vaccine protective antigens (Artigas-Jerónimo, De La Fuente, & Villar, 2018; Contreras et al., 
9 2018).
10 The clinical and clinicopathological findings observed in CanL are the consequence of complex 
11 interactions between the parasite and the genetic and immunological response of the dog, 
12 making CanL a very pleomorphic disease (L. Solano-Gallego et al., 2009). Dogs present clinical 
13 CanL when they exhibit clinical signs and/or clinicopathological abnormalities and a confirmed L. 
14 infantum infection. There are established guidelines such as the LeishVet guidelines (Solano-
15 Gallego et al., 2011)   published, in which animals are classified in different clinical stages 
16 according to their physical examination and laboratory findings. For example, in this guide, the 
17 ‘Moderate disease, Stage IIa’ includes dogs with medium to high positive antibody titers and 
18 clinicopathological abnormalities that may include hypoalbuminemia, hyperglobulinemia, mild 
19 non-regenerative anemia, and a normal renal profile (creatinine < 1.4 mg/dl and non-proteinuric 
20 profile with UPC < 0.5). Externally, dogs in clinical stage II may present anorexia, weight loss, 
21 peripheral lymphadenomegaly, cutaneous lesions, fever, or epistaxis, among other clinical signs.
22 On the other hand, there are dogs with confirmed L. infantum infection that do not present 
23 clinical signs or clinicopathological abnormalities, which are considered subclinical infected or 
24 healthy infected asymptomatic dogs. Before the appearance of clinical signs of CanL in dogs, a 
25 subclinical phase usually occurs that can last a few months which can evolve into a disease with 
26 clinical manifestations. In previous reports (Martinez-Subiela, Strauss-Ayali, Cerón, & Baneth, 
27 2011; Paltrinieri, Gradoni, Roura, Zatelli, & Zini, n.d.), a moderate increase of acute phase 
28 proteins such as C-reactive protein and ferritin has been observed previous to the appearance of 
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1 reservoirs for other dogs, humans and other species (Ashford et al., 1993). Additionally, the early 
2 detection and close follow up of these dogs would allow them an early treatment that may result 
3 in a better quality of life and expectancy.
4 The objective of this study was to analyse the serum proteome changes that occur during the 
5 subclinical and clinical stages of CanL in the same dogs, using an experimental infection model. 
6 This study could help us in the understanding of the CanL physiopathology and the changes that 
7 are responsible of the onset of the disease and could potentially help to identify new early 
8 biomarkers of the disease progression and pathology.
9
10 2. Material and Methods
11 2.1. Animals, sample procedures and experimental design
12 A total of 4 beagle dogs bought from Isoquimen S.L. (Barcelona, Spain) were involved in this 
13 study, which was made in the University of Murcia installations (south-eastern Spain). All dogs 
14 were negative to the presence of L. infantum (tested by Enzyme-Linked ImmunoSorbent Assay 
15 (ELISA) and real-time polymerase chain reaction (qPCR) of lymph node and bone marrow 
16 aspirates) and Dirofilaria immitis, Anaplasma Phagocytophilum, Borrelia Burgdorferi, and 
17 Ehrlichia Canis antibodies (using the IDEXX SNAP® 4Dx® Test, IDEXX laboratories, IDEXX Europe 
18 B.V., Hoofddorp, The Netherlands). 
19 All the procedures were approved by University of Murcia Animal Ethics Committee (protocol 
20 number: 276/2016) and the Regional government of Murcia (identification code number: 
21 A13151002), and were performed in compliance with the law RD53/2013 about animal 
22 experimentation in Spain.
23 Dogs were submitted to an experimental infection with L. infantum through intravenous 
24 injection with 1×106 stationary-phase infective L. infantum (MCAN/BR/00/BA262) promastigotes. 
25 L. infantum parasites (amastigotes form) were isolated from spleen of an experimentally infected 
26 hamster and cultured in Schneider’s Drosophila medium (Biowest) supplemented with 10% of 
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1 from the splenic amastigotes were cultured in modified RPMI-1640 medium supplemented with 
2 20% of iFBS, and 50 µg/mL gentamicin at 26°C. Parasite shape and motility was examined by 
3 microscopic examination. With the aim of avoiding re-infections by L. infantum during the study, 
4 all dogs were externally dewormed with an anti-sandfly activity insecticide (permethrin 
5 500mg/ml and imidacloprid 100mg/ml, Advantix pipettes, Bayer®) every three weeks and 
6 internally dewormed (50mg praziquantel, 50 mg pyrantel and 150 mg febantel; Prazitel tablets, 
7 Ecuphar®) in accordance with manufacturer’s instructions. In addition, dogs were fed with an 
8 equilibrated and high quality dry dog food (Affinity Libra Adult with Chicken, Affinity®) 
9 throughout the study. 
10 Blood samples (10 ml) were collected by venipuncture of the jugular vein in tubes containing 
11 a coagulation activator and a gel separator and kept at room temperature (25ºC) until visible clot 
12 reaction. Samples were centrifuged at 3.500 rpm for 5 min and serum were separated and stored 
13 at -80ºC until analysis. During the study, external clinical examination –performed by a licensed 
14 veterinarian (LB)-, haematology, and serum biochemistry analyses were performed monthly. 
15 Quantitative PCR was performed in bone marrow at least every two months.. 
16 For the present study, blood samples from three different time points (pre-infection, T0, and 
17 2 different times post-infection, T1 and T2) were employed. All the pre-infection samples 
18 resulted L. infantum-negative and all post-infection samples tested were L. infantum-positive by 
19 quantitative real-time PCR of bone marrow aspirates. For bone marrow extraction, dogs were 
20 submitted to sedation with medetomidine (Domtor®) and butorphanol (Torbugesic®). At each 
21 time point, the presence of Dirofilaria immitis, Anaplasma Phagocytophylum, Borrelia 
22 Burgdorferi, and Ehrlichia Canis antibodies were discharged using the Canine SNAP 4Dx test 
23 (IDEXX laboratories, IDEXX Europe B.V., Hoofddorp, The Netherlands). Quantitative polymerase 
24 chain reaction (qPCR) of bone marrow was negative results at T0, and positive at T1 and T2 in all 
25 the animals (data not show).
26 For the same four animals, pre-infection samples were selected for T0, those time points in 
27 which ferritin and CRP were increased in serum were selected for T1; and the time points 
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1 anorexia, weight loss, peripheral lymphadenomegaly, cutaneous lesions or fever) were selected 
2 for T2 (Table 1). None of the animals presented any abnormalities by external examination at T1.
3 2.3. Trypsin digestion of serum proteins. 
4 Serum protein extracts (100 μg serum from each dog in every time point), were 
5 methanol/chloroform precipitated and resuspended in 30 μl of sample buffer. Proteins were gel 
6 concentrated, trypsin digested and the resulting peptides desalted as previously described (Villar 
7 et al., 2015). Samples were stored at – 20 ºC until mass spectrometry analysis.  
8 2.4. Serum proteome analysis by SWATH-MS.  
9 The desalted protein digests were resuspended in water containing 2% acetonitrile and 5% 
10 formic acid and analysed by reverse phase liquid chromatography coupled online with mass 
11 spectrometry (RP-LC-MS/MS) using an ekspertTM nanoLC 415 system coupled to a 6600 
12 TripleTOF® mass spectrometer (AB SCIEX; Framingham, US) through Information-Dependent 
13 Acquisition (IDA) followed by SWATH (Sequential Windowed data independent Acquisition of the 
14 Total High-resolution Mass Spectra). Approximately 2 μg of each protein digest of sera from the 
15 four dogs in each condition (T0, T1 and T2) were pooled and used for the generation of the 
16 reference spectral ion library as part of SWATH-MS analysis. The peptides were concentrated 
17 using a 0.1×20 mm C18 RP precolumn (Thermo Scientific), and then separated using a 0.075×250 
18 mm C18 RP column (New Objective, Woburn, MA, USA) operating at 300 nl/min. Peptides were 
19 eluted in a 120-min gradient from 5 to 30% solvent A (0,1% formic acid in water) followed by 10-
20 min gradient from 30 to 60% solvent B (0,1% formic acid in acetonitrile) and directly injected into 
21 the mass spectrometer for analysis. 
22 For IDA experiments, the mass spectrometer was set to scanning full spectra (390-1400 m/z) 
23 using 250ms accumulation time per spectrum, followed by up to 50 MS/MS scans (100-1500 
24 m/z). Candidate ions with a charge state between +2 and +5, and counts per second above a 
25 minimum threshold of 100, were isolated for fragmentation. One MS/MS spectra was collected 
26 for 100 ms, before adding those precursor ions to the exclusion list for 15 s (mass spectrometer 
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1 analyses were recorded in high sensitivity mode with rolling collision energy on and a collision 
2 energy spread of 5.
3 For SWATH quantitative analysis, 5 μg of each independent sample were subjected to the cyclic 
4 data independent acquisition (DIA) of mass spectra using the SWATH variable windows calculator 
5 (V 1.0, AB SCIEX) and the SWATH acquisition method editor (AB SCIEX), similar to previously 
6 established methods (Gillet et al., 2012). A set of 50 overlapping windows was constructed 
7 (containing 1 m/z for the window overlap), covering the precursor mass range of 400–1250 m/z. 
8 For these experiments, a 50 ms survey scan (390–1400 m/z) was acquired at the beginning of 
9 each cycle, and SWATH-MS/MS spectra were collected from 100–1500 m/z for 70 ms at high 
10 sensitivity mode, resulting in a cycle time of 3.6 s. Collision energy for each window was 
11 determined according to the calculation for a charge +2 ion-centered upon the window with a 
12 collision energy spread of 15.
13 2.5. Library generation/protein identification, data processing and relative quantitation. 
14 To create a spectral library of all the detectable peptides in the samples, the IDA MS raw files 
15 were combined and subjected to database searches in unison using ProteinPilot software v. 5.0.1 
16 (AB SCIEX; Framingham, US) with the Paragon algorithm. Spectra identification was performed by 
17 searching against a complied database containing all sequences from Canis lupus familiaris 
18 proteome and Leishmania taxonomy (Uniprot databases: 25,491 and 58,760 entries, 
19 respectively, in May, 2018) with the following parameters: iodoacetamide cysteine alkylation, 
20 trypsin digestion, gel-based ID as special factor, identification focus on biological modification 
21 and thorough ID as search effort. The detected protein threshold was set at 0.05. An 
22 independent False Discovery Rate (FDR) analysis, using the target- decoy approach provided by 
23 Protein PilotTM, was used to assess the quality of identifications. Positive identifications were 
24 considered when identified proteins reached a 1% global FDR. 
25 For SWATH processing, up to ten peptides with seven transitions per protein were automatically 
26 selected by the SWATH Acquisition MicroApp 2.0 in the PeakView 2.2 software with the following 
27 parameters: 15 ppm ion library tolerance, 5 min XIC extraction window, 0.01 Da XIC width, and 
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1 or contained modifications. However, to ensure reliable quantitation, only proteins with 3 or 
2 more peptides available for quantitation were selected for XIC peak area extraction and exported 
3 for analysis in the MarkerView 1.3 software (AB SCIEX). Global normalization was performed 
4 according to the Total Area Sums of all detected proteins in the samples. A Student's T-test 
5 (Gaussian distribution, paired comparison) was used to perform two-sample comparisons 
6 between the averaged area sums of all the transitions derived for each protein across the four 
7 replicate runs for each sample under comparison, in order to identify proteins that were 
8 significantly differentially represented between samples (T0 to T1, T0 to T1 and T1 to T2). Fold 
9 changes (FC) have been calculated as follow FC= Group 2/Group 1, being T1/T0, T2/T0, and T2/T1 
10 for their respective comparisons. The mass spectrometry proteomics data have been deposited 
11 at the PeptideAtlas repository (http://www.peptideatlas.org/) with the dataset identifier 
12 PASS01352.
13 2.6. Bioinformatics and GO pathways
14 Proteomics data were used for Gene Ontology (GO) analysis. Canine genes encoding proteins 
15 differentially expressed were converted to their human orthologs using the Ensembl orthologs 
16 database and its BioMart tool for data mining (www.ensembl.org). Obtained genes were used to 
17 determine the GO terms over-represented in three conditions (T0, T1, and T2), by the utilization 
18 of through Protein Analysis Through Evolutionary Relationships (PANTHER) classification tool. 
19 Venn diagrams of proteins differentially expressed were drawn through the online software 
20 “Calculate and draw custom Venn diagrams” 
21 (http://bioinformatics.psb.ugent.be/webtools/Venn/). 
22 2.7. Haptoglobin verification
23 For haptoglobin (Hp) verification, serum samples from client-owned dogs positive to CanL by 
24 serology presented at private veterinary clinics of Murcia Region for routine check-ups were 
25 assessed for inclusion. Dogs were classified as symptomatic and asymptomatic according to 
26 external examination performed by licensed veterinarians. The dogs were excluded of the study 
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1 overnight fasting by cephalic venepuncture. Blood was clotted at room temperature and 
2 centrifugation (3700g for 10 min, 20ºC) was performed for serum separation.
3 Serum haptoglobin concentration was measured by a commercially available colorimetric 
4 method (kit haptoglobin Tridelta phase range, Tridelta Development) that was previously 
5 validated for its use in dog (Martinez-Subiela & Cerón, 2005). Haptoglobin was expressed in g/L. 
6 The results for haptoglobin were evaluated for normality of distribution using D’Agostino and 
7 Pearson omnibus normality test statistics. Since the date was non-normally distributed, Mann–
8 Whitney U test was used to compare concentrations. Analysis was performed using statistical 
9 software (GraphPad), and values of P < 0.05 were considered significant.
10 3. Results
11 3.1. Quantitative proteomics analysis revealed changes in serum proteome during the course of 
12 CanL infection 
13 Proteomics analysis allowed the identification of 169 proteins from Canis Lupus familiaris 
14 proteome with FDR ≤ 1% from the eighteen non-depleted canine serum samples (Suppl table 1). 
15 A total of 44 proteins were differentially represented between the different time periods: 1 
16 protein between T0 and T1, 13 when compared T0 and T2, and 30 proteins between T1 and T2 
17 (Table 2). No proteins were identified by comparing our results with Leishmania taxonomy 
18 database.
19 Complement C8 alpha chain (C8A) was the only protein that changed in abundance between T0 
20 and T1, with a 2.24-fold decrease. At T2, sphingomyelin phosphodiesterase acid like 3A 
21 (SMPDL3A), leucine rich alpha-2-glycoprotein (LRG1), inter-alpha-trypsin inhibitor heavy chain 
22 (ITIH2), hyaluronan binding protein 2 (HABP2), serpin family A member 3 and member 4 
23 (SERPINA 3, and SERPINA 4, respectively), complement C9 (C9), and sulfhydryl oxidase (QSOX1) 
24 were over-represented when compared to pre-infection levels. When the subclinical (T1) and 
25 clinical stages (T2) were compared, adiponectin (ADIPOQ) and transferrin (TF) were the only 
26 proteins under-represented at T2 when compared to T1, while C8A, SMPDL3A, tranketolase 
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1 gamma chain (FGG), HABP2, lymphocyte cytosolic protein 1 (LCP1), haptoglobin (HP), hepatocyte 
2 growth factor activator (HGFAC), and SERPIN A3 were over-represented at T2.
3
4 3.2. Identification of biological processes involved in CanL by proteomics and bioinformatics 
5 analyses 
6 The biological processes in which the proteins differentially expressed between the different 
7 stages of CanL infection are shown as Venn diagrams in Figure 1a. Complement C8 alpha chain 
8 was identified as the only common protein significantly modulated when comparing T0 vs T1 and 
9 T1 vs T2. Nine common proteins, identified as sphingomyelin phosphodiesterase acid like 3A, 
10 hyaluronan binding protein 2, leucine rich alpha-2-glycoprotein 1, serpin family A member 3, and 
11 still uncharacterized proteins L7N0P9_CANLF, F1PF90_CANLF, F1PQU0_CANLF, F1PG16_CANLF, 
12 and J9NSQ1_CANLF, were found significantly modulated when T0 vs T2 and T1 vs T2 were 
13 compared. In addition, four proteins were differently represented only in T0vsT2, while 20 
14 proteins showed differences only between T1 and T2. 
15 These 44 proteins differentially expressed between the different time points were used for a 
16 qualitative analysis in terms of functional clusters, according to the PANTHER classification 
17 system (http://www.pantherdb.org) (Figures 1b-d). The identified differentially modulated 
18 proteins between the different time points were distributed into 4 different molecular functions 
19 namely catalytic activity (47.4%), binding (31.6%), molecular function regulator (15.8%), and 
20 transporter activity (5.3%). These proteins are involved in 10 different biological processes, being 
21 response to stimulus, metabolic process, and biological regulation the most represented ones 
22 with 34.2, 18.4, and 13.2% of proteins, respectively. Regarding biological pathways, the 
23 differentially modulated proteins participated in blood coagulation, gonadotropin-releasing 
24 hormone receptor pathway, pentose phosphate pathway, and plasminogen activating cascade 
25 (25% of proteins for each one).
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1 A total of 60 dogs of different breeds were included for haptoglobin verification. Thirty-three dogs (47% 
2 males, 6.8 ± 2.95 years old) were classified as symptomatic, while twenty-seven (37% males, 5.9 ± 2.6 
3 years old) were considered as asymptomatic. No statistical significant difference was detected in age 
4 between the two groups (p=0.301). 
5  Statistically higher serum concentrations of Hp were observed in dogs with clinical signs of CanL when 
6 compared to asymptomatic positive to Leishmania dogs (4.62 [3.08 – 5.28] versus [2.36 [1.15 – 5.17] g/L, 
7 respectively) (p= 0.013).
8
9 4. Discussion
10 In the present study, a proteomics study in serum of healthy (pre-infection), subclinical 
11 (asymptomatic), and clinical symptomatic stages of canine leishmaniosis was performed using 
12 TMT. The use of an experimental infection model allowed the study and monitoring the changes 
13 in the protein expression patters over time in the same animal. The subclinical stage was selected 
14 according to previously published criteria in which dogs do not have external clinical signs of 
15 infection but an increase in acute phase proteins, this being considered as a phase leading to the 
16 clinical stage that can differ in length depending of the individual (Paltrinieri et al., 2010). 
17 In dog sera, the complement C8 alpha chain (C8A) was the only protein that was significantly 
18 decreased at pre-symptomatic phase (T1) in comparison to pre-infection (T0) values. 
19 Complement C8 is a constituent of the membrane attack complex being inserted into the target 
20 membrane forming pores (Hadders, Beringer, & Gros, 2007). The activation of complement has 
21 proven to be partially effective against Leishmania promastigotes, being able to kill most of the 
22 parasites (Solbach & Laskay, 1999). Complement activation has been correlated with absence of 
23 parasites in the skin macrophages of following cutaneous Leishmania inoculation (de Amorim et 
24 al., 2011). Thus, the decrease on C8A at the pre-symptomatic phase could be compatible with a 
25 less effective response of the dogs and the subsequent onset of the disease.
26 When abundances of proteins were compared between subclinical (T1) and symptomatic (T2) 
27 phases, adiponectin (ADIPOQ) and transferrin (TF) were the only proteins that significantly 
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1 and reduces plasma glucose concentrations besides promoting fatty acid oxidation. In addition, 
2 adiponectin is related to inflammation and immune response (Berg & Scherer, 2005; Yamauchi et 
3 al., 2002), being down-regulated in several inflammatory conditions such as obesity and 
4 metabolic syndrome (Asta Tvarijonaviciute et al., 2012), acute pancreatitis(Paek et al., 2014), and 
5 diabetes mellitus (Kim, Kim, Kang, & Yang, 2015). In CanL, adiponectin has been shown to be 
6 down-regulated in sera of dogs with clinical signs, when compared to healthy dogs (A. 
7 Tvarijonaviciute, Ceron, Martinez-Subiela, & García-Martinez, 2012), which is in concordance 
8 with our results. However, to the authors’ best knowledge, the decrease of adiponectin in 
9 symptomatic dogs in comparison with the pre-symptomatic phase was not previously reported. 
10 On the other hand, transferrin is responsible for the iron transport into the circulatory torrent 
11 and acts as a negative acute phase protein in dogs (Cerón, Eckersall, & Martínez-Subiela, 2005). 
12 Similarly to our results, decreased serum transferrin levels have been reported in symptomatic 
13 dogs with CanL when compared to healthy animals due to the caused inflammation (Burillo, 
14 Perez, Liesa, & Fabian, 1994; Silvestrini et al., 2014) being increased and restored after an 
15 effective anti-leishmania treatment (Martínez-Subiela et al., 2017). However, there are no 
16 reports of serum transferrin levels among the different stages of CanL. Overall, the data obtained 
17 in this manuscript with increases in ferritin and decreases in transferrin indicate that there is an 
18 alteration in iron metabolism in CanL. Although it was not measured in this study, the increase in 
19 ferritin and decrease in transferrin would indicate an increase of storage of iron and decrease in 
20 its transportation to blood respectively, that would lead to a decrease in serum iron, as it has 
21 previously described in dogs with clinical leishmaniosis (Silvestrini et al., 2014).
22 The abundance of a total of 28 proteins showed to be increased at T2 when compared to T1, 
23 being from 1.48 to 3.21-fold higher. Among them, C8A and several uncharacterized proteins 
24 (compatible with immunoglobulins according to their BLAST sequence) were the most up-
25 regulated. This increase of C8A level could be related to the activation of complement cascade, 
26 similarly to that described in the case of other inflammatory diseases such as canine babesiosis 
27 (Kuleš et al., 2014) or parvovirosis (Franco-Martínez et al., 2018). Thus, the increase in C8A could 
28 point out the activation of complement cascade in response to the diffusion of Leishmania 
29 through the organism. It is interesting to note the dynamics of C8A in the experimental infection, 
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1 subclinical stage and an increased level when the clinical signs appear. The observed progressive 
2 increase in the serum level of several immunoglobulins during the development of CanL was 
3 expected since hyperglobulinemia was detected by serum biochemistry (Table 1) and because it 
4 has been extensively studied in CanL, being serological assays based on the detection of specific 
5 anti-Leishmania antibodies in serum considered as one of the current diagnostic techniques (Laia 
6 Solano-Gallego et al., 2014). According to their BLAST sequence, different types of 
7 immunoglobulins were found to increase in abundance during the onset of the disease, which 
8 may point out different mechanisms such as the enhancement of Th2 response against the 
9 infection -which has been proven to be an ineffective response against leishmaniosis leading to 
10 the onset of the disease-, and also the development of a non-specific antibody production, as 
11 described previously (Silva-Barrios et al., 2016). In the clinical stage of the disease (T2), all the 
12 proteins that were significantly modulated in comparison with pre-infection (T0) measurements 
13 were up-regulated, with increasing rates ranging from 1.45 up to 3.48-fold higher. Of these 13 
14 proteins, two uncharacterized proteins (L7N0P9_CANLF and F1PF90_CANLF) and sphingomyelin 
15 phosphodiesterase acid like 3A (SMPDL3A) were the most up-regulated. BLAST analyses and 
16 sequence comparison with proteins of know function suggested that the two uncharacterized 
17 proteins corresponded to immunoglobulins (immunoglobulin kappa light chain variable region 
18 [Canis lupus familiaris] [89.34% identity; 96% query cover] and immunoglobulin iota chain-like 
19 [Canis lupus familiaris] [95.65% identity; 99% query cover], respectively). SMPDL3A is a 
20 nucleotide phosphodiesterase for nucleoside triphosphates such as ATP, and lesser activity with 
21 nucleoside diphosphates. This protein is detected in macrophages, and is known to be up-
22 regulated in macrophages in response to cholesterol accumulation and by cAMP (Traini et al., 
23 2014). Since extracellular nucleotides may activate pro-inflammatory responses in immune cells, 
24 SMPDL3A has been proposed as a potentially novel anti-inflammatory protein by decreasing the 
25 concentration of these pro-inflammatory nucleotides (Traini et al., 2014). According to Panther 
26 system classification, the differentially modulated proteins that were found among the 
27 subclinical and clinical stages of CanL are mainly related to blood coagulation, gonadotropin-
28 releasing hormone receptor pathway, pentose phosphate, and plasminogen activating cascade 
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1 function regulation, and transporter activity. Therefore, these systems and functions are affected 
2 when the disease is symptomatic.
3 Finally, one of the identified proteins by proteomic studies was verified as a possible marker for the 
4 follow-up of canine leishmaniosis. Haptoglobin was selected because it could be easily measured 
5 by validated methods for its use in dogs; and because it has been previously proposed as 
6 biomarker for CanL diagnosis (Cantos-Barreda et al., 2018) or response to treatment, decreasing 
7 after an effective anti-leishmania treatment (Martinez-Subiela et al., 2011). However, to the best 
8 of the author’s knowledge, this is the first report in which Hp is observed to change by a high-
9 throughput proteomic approach during the development of CanL in experimentally infected 
10 dogs; followed by its verification in dog naturally infected by Leishmania at symptomatic and 
11 asymptomatic stages. Our results showed that Hp concentrations were higher in symptomatic 
12 dogs in both experiments, which was in agreement with previous literature (Cantos-Barreda et 
13 al., 2018), proposing serum Hp as a feasible biomarker of diagnosis and severity of CanL. Further 
14 studies would be desirable to verified other differentially represented proteins as possible 
15 biomarkers for CanL.
16 The results obtained in the present study should be interpreted with caution due to the low 
17 sample size and because the changes observed after the experimental infection could differ from 
18 those dogs naturally infected and among the different clinical stage. Thus, the corroboration of 
19 our results with in a larger amount of dogs, and also compared with those obtained from 
20 naturally infected dogs at the different clinical stages of CanL according to the established 
21 guidelines such as the Leishvet would provide with further insight in the early detection or 
22 predicting the outcome in canine leishmaniosis. Finally, the proteomic approach employed in the 
23 present study could be of utility to the further knowledge of other diseases such as canine 
24 ehrlichiosis, babesiosis or filariosis, and have already applied for other important canine diseases 
25 such as parvoviral enteritis. The comparative analysis of the changes in serum proteome due to 
26 these diseases and in animals presenting co-infections could be of great value in the 
27 understanding of the pathological mechanisms of the diseases and for the search for new 
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Table 1. Main clinicopathological findings in dogs with clinical CanL and clinical stages based on LeishVet guidelines at the moment of T2 (Laia Solano-Gallego et al., 2011).
T1 T2
Gender / age in 





CRP Ferritine Weight Days 
from 
T0
CRP Ferritine External examination Laboratory abnormalities Clinical stage 
(Leishvet)
1 Male/ 1 /17.5 17.2 168 34.2 421.4 16.1 211 97.7 901.5 Lymphadenomegaly 






Increased CRP and 
ferritine
II a
2 Male/1 /18.5 18.3 168 6.8 263.1 17.1 211 38.7 748 Lymphadenomegaly 






Increased CRP and 
ferritine
II a
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Ocular lesions (blepharitis) Increased CRP and 
ferritine




Increased CRP, ferritine, 
ALP, AST and ALT
II a
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Table 2. Identification by SWATH-MS of differentially expressed seric proteins in dogs before (T0) and after (T1 and 
T2) experimental infection with L. infantum.
Accession number Protein identity T1/T0 T2/T0 T2/T1
E2R109 Complement C8 alpha chain 0,38 3,49
L7N0P9 Uncharacterized protein † 3,48 2,75
J9NYQ3 Sphingomyelin phosphodiesterase acid like 3A 2,98 2,57
F1PF90 Uncharacterized protein † 2,30 3,49
J9NSS7 Leucine rich alpha-2-glycoprotein 1 1,96 2,20
F1PQU0 Uncharacterized protein 1,88 2,64
F1PG16 Uncharacterized protein 1,81 1,86
J9NSQ1 Uncharacterized protein  † 1,78 3,16
F1PG39 Inter-alpha-trypsin inhibitor heavy chain 2 1,68
F1Q1K9 Hyaluronan binding protein 2 1,67 1,77
F1PH87 Serpin family A member 3 1,48 1,47
F1PHN8 Serpin family A member 4 1,47
E2RFV9 Complement C9 1,45
F1PLT8 Sulfhydryl oxidase 1,45
J9P0D4 Uncharacterized protein † 3,25
F1PKN5 Uncharacterized protein † 2,59
F1PE28 Transketolase 2,46
F1PDJ7 Uncharacterized protein 2,42
APOA4 Apolipoprotein A-IV 2,18
J9NWG4 Uncharacterized protein 1,98
L7N0E7 Uncharacterized protein  † 1,92
J9PAW5 Uncharacterized protein † 1,89
F1PA63 Lecithin-cholesterol acyltransferase 1,88
E2QW61 Uncharacterized protein 1,85
J9P6L3 Uncharacterized protein † 1,85
J9P1F6 Uncharacterized protein † 1,83
F1P8G0 Fibrinogen gamma chain 1,83
E2QWN7 Lymphocyte cytosolic protein 1 1,72
G1K2D9 Haptoglobin 1,63
F1Q184 Uncharacterized protein † 1,63
J9P050 Uncharacterized protein † 1,58
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A0A0B4J198 Adiponectin, C1Q and collagen domain containing 0,76
J9P430 Transferrin   0,71
* Accession number from Uniprot protein database for Canis lupus familiaris (www.uniprot.org)
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Figure legends
Figure 1. a) Venn Diagrams showing the unique and common differentially represented proteins 
at the different times performed. One common protein was identified as significantly modulated 
when comparing T0vsT1 and T1vsT2. 9 common proteins were identified as significantly 
deregulated in symptomatic animals when comparing T0vsT2 and T1vsT2. Additionally, T0vsT2 
and T1vsT2 showed 4 and 20 unique proteins differentially expressed, respectively. b-d) Pie chart 
showing the molecular function, biological process, and pathways as a percentage of the 44 
distinct identified proteins based on the PANTHER classification system. 
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